New CAR t therapy aims to control Hard-to-Treat multiple myeloma
NCT ID NCT07510100
First seen Apr 03, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This early-stage study tests a new treatment called Equecabtagene Autoleucel (a CAR T-cell therapy) for people with multiple myeloma that has returned or stopped responding to at least three prior treatments. The therapy uses a patient's own immune cells, which are modified in a lab to target and attack cancer cells. The study will enroll 17 participants to check for side effects and see how well the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institute of Science Tokyo Hospital
Bunkyo-ku, Tokyo, 113-8519, Japan
Contact
-
Japanese Red Cross Medical Center
Shibuya-ku, Tokyo, 150-8935, Japan
Contact
-
Nihon University Itabashi Hospital
Itabashi-ku, Tokyo, 173-8610, Japan
Contact
Conditions
Explore the condition pages connected to this study.